This case highlights the need for immunohistochemical profiling of patients with multiple breast nodules and a history of ...

Rebecca Keen believes a full-body MRI may have saved her life, but doctors say getting one could cause more harm than good.

The findings contradict previous research suggesting high-risk patients with multiple myeloma were more likely to have a ...

Multiple myeloma (MM) is a form of blood cancer that originates from plasma cells – part of the white blood cell produced by the bone marrow responsible for providing the human body with the ...

This approval comes almost a year after the drug received a complete response letter due to third-party manufacturing issues.

New research presented by Noella Collado-Gisbert reveals that tracking residual disease kinetics in multiple myeloma predicts long-term survival and supports early treatment strategies to prevent ...

Breakthrough Trispecific Antibody Shows Strong Early Efficacy: JNJ-5322 demonstrated an 86.1% overall response rate (ORR) at the recommended Phase II dose in heavily pretreated multiple myeloma ...

Single-dose CAR-T therapy potentially curative in multiple myeloma by Justin Jackson, Phys.org edited by Sadie Harley, reviewed by Robert Egan Editors' notes ...

Multiple myeloma causes lytic or osteolytic lesions, which are areas of damage caused by cancerous plasma cells blocking normal bone growth. While painful, they can be managed. Multiple myeloma is ...

While it is considered a rare cancer, multiple myeloma poses a significant global health challenge due to its complex nature affecting vital organs and high recurrence rates. According to the ...

Cardiac MRI images showing heart structure (left) and tissue changes in a female participant from the research study. The colour maps (centre and right) reveal signs of inflammation, helping ...